Hepalink Pharmaceutical-B (02142) fell over 6% during trading, and as of the time of publication, fell 4.83% to HKD 1.38 with a turnover of 1.9591 million Hong Kong dollars.
According to the Zhitong Finance App, Hepalink Pharmaceutical-B (02142) fell over 6% during trading, and as of the time of publication, fell 4.83% to HKD 1.38 with a turnover of 1.9591 million Hong Kong dollars.
On the news front, Hepalink Pharmaceutical issued a profit warning, expecting a profit of approximately US$1 million to US$1.5 million for the six months ending June 30, 2024. This is a decrease of approximately 48.3% to 65.5% compared to the same period last year, when the profit was around US$ 2.9 million. The announcement stated that the decrease in expected profits is mainly due to changes in the income structure, especially the increased proportion of service fees from the services business compared to the first half of last year's revenue. However, compared to the large proportion of authorized income in last year's revenue, the profit margin of this type of income is relatively low. Therefore, the overall profit for the first half of this year has decreased.